TCT-342 Risk and Consequences of Periprocedural Myocardial Infarction Following Off-Label Use of Second Generation Drug-Eluting Stents: Two-Year Follow-up in the TWENTE Trial

Hanim Sen, Ming Kai Lam, Kenneth Tandjung, Mounir W. Basalus, Martin G. Stoel, Gert K. van Houwelingen, F. de Man, Hans W. Louwerenburg, Gerard C. Linssen, Mark B. Nienhuis, Marije M. Löwik, Job van der Palen, Clemens von Birgelen

Research output: Contribution to journalArticleAcademicpeer-review

45 Downloads (Pure)
Original languageEnglish
Pages (from-to)B109-B109
JournalJournal of the American College of Cardiology
Issue number18, Suppl. 1
Publication statusPublished - 2013
Event25th Annual Scientific Symposium of Transcatheter Cardiovascular Therapeutics, TCT 2013 - San Francisco, United States
Duration: 27 Oct 20131 Nov 2013
Conference number: 25


  • METIS-302487
  • IR-89482

Cite this